Global RNA Based Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 91 pages | ID: G36A34768033EN
LP Information

Abstracts

According to this study, the global RNA Based Therapeutics market size will reach US$ million by 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “RNA Based Therapeutics Industry Forecast” looks at past sales and reviews total world RNA Based Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected RNA Based Therapeutics sales for 2025 through 2031. With RNA Based Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNA Based Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global RNA Based Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on RNA Based Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RNA Based Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNA Based Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNA Based Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of RNA Based Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• qRT-PCR
• RNA Interference (RNAi) Technologies
• RNA Antisense
• Inhibition
• Microarrays
• Labeling
• Purification

Segmentation by Application:

• Cardiovascular
• Kidney Diseases
• Oncology
• Infectious Diseases
• Metabolic Disorders

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• ISIS pharmaceuticals (USA)
• Quark Pharmaceuticals (USA)
• Alnylam Pharmaceuticals (USA)
• Dicerna Pharmaceuticals (USA)
• Tekmira Pharmaceuticals Corp. (Canada)
• Benitec Biopharma Limited (Australia)
• Genzyme Corporation (USA)
• Silence Therapeutics PLC (UK)
• Cenix BioScience GmbH (Germany)

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global RNA Based Therapeutics Market Size (2020-2031)
  2.1.2 RNA Based Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for RNA Based Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 RNA Based Therapeutics Segment by Type
  2.2.1 qRT-PCR
  2.2.2 RNA Interference (RNAi) Technologies
  2.2.3 RNA Antisense
  2.2.4 Inhibition
  2.2.5 Microarrays
  2.2.6 Labeling
  2.2.7 Purification
2.3 RNA Based Therapeutics Market Size by Type
  2.3.1 RNA Based Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global RNA Based Therapeutics Market Size Market Share by Type (2020-2025)
2.4 RNA Based Therapeutics Segment by Application
  2.4.1 Cardiovascular
  2.4.2 Kidney Diseases
  2.4.3 Oncology
  2.4.4 Infectious Diseases
  2.4.5 Metabolic Disorders
2.5 RNA Based Therapeutics Market Size by Application
  2.5.1 RNA Based Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global RNA Based Therapeutics Market Size Market Share by Application (2020-2025)

3 RNA BASED THERAPEUTICS MARKET SIZE BY PLAYER

3.1 RNA Based Therapeutics Market Size Market Share by Player
  3.1.1 Global RNA Based Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global RNA Based Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global RNA Based Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RNA BASED THERAPEUTICS BY REGION

4.1 RNA Based Therapeutics Market Size by Region (2020-2025)
4.2 Global RNA Based Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas RNA Based Therapeutics Market Size Growth (2020-2025)
4.4 APAC RNA Based Therapeutics Market Size Growth (2020-2025)
4.5 Europe RNA Based Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa RNA Based Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas RNA Based Therapeutics Market Size by Country (2020-2025)
5.2 Americas RNA Based Therapeutics Market Size by Type (2020-2025)
5.3 Americas RNA Based Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC RNA Based Therapeutics Market Size by Region (2020-2025)
6.2 APAC RNA Based Therapeutics Market Size by Type (2020-2025)
6.3 APAC RNA Based Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe RNA Based Therapeutics Market Size by Country (2020-2025)
7.2 Europe RNA Based Therapeutics Market Size by Type (2020-2025)
7.3 Europe RNA Based Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa RNA Based Therapeutics by Region (2020-2025)
8.2 Middle East & Africa RNA Based Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa RNA Based Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RNA BASED THERAPEUTICS MARKET FORECAST

10.1 Global RNA Based Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global RNA Based Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas RNA Based Therapeutics Forecast
  10.1.3 APAC RNA Based Therapeutics Forecast
  10.1.4 Europe RNA Based Therapeutics Forecast
  10.1.5 Middle East & Africa RNA Based Therapeutics Forecast
10.2 Americas RNA Based Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market RNA Based Therapeutics Forecast
  10.2.2 Canada Market RNA Based Therapeutics Forecast
  10.2.3 Mexico Market RNA Based Therapeutics Forecast
  10.2.4 Brazil Market RNA Based Therapeutics Forecast
10.3 APAC RNA Based Therapeutics Forecast by Region (2026-2031)
  10.3.1 China RNA Based Therapeutics Market Forecast
  10.3.2 Japan Market RNA Based Therapeutics Forecast
  10.3.3 Korea Market RNA Based Therapeutics Forecast
  10.3.4 Southeast Asia Market RNA Based Therapeutics Forecast
  10.3.5 India Market RNA Based Therapeutics Forecast
  10.3.6 Australia Market RNA Based Therapeutics Forecast
10.4 Europe RNA Based Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market RNA Based Therapeutics Forecast
  10.4.2 France Market RNA Based Therapeutics Forecast
  10.4.3 UK Market RNA Based Therapeutics Forecast
  10.4.4 Italy Market RNA Based Therapeutics Forecast
  10.4.5 Russia Market RNA Based Therapeutics Forecast
10.5 Middle East & Africa RNA Based Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market RNA Based Therapeutics Forecast
  10.5.2 South Africa Market RNA Based Therapeutics Forecast
  10.5.3 Israel Market RNA Based Therapeutics Forecast
  10.5.4 Turkey Market RNA Based Therapeutics Forecast
10.6 Global RNA Based Therapeutics Forecast by Type (2026-2031)
10.7 Global RNA Based Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market RNA Based Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 ISIS pharmaceuticals (USA)
  11.1.1 ISIS pharmaceuticals (USA) Company Information
  11.1.2 ISIS pharmaceuticals (USA) RNA Based Therapeutics Product Offered
  11.1.3 ISIS pharmaceuticals (USA) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 ISIS pharmaceuticals (USA) Main Business Overview
  11.1.5 ISIS pharmaceuticals (USA) Latest Developments
11.2 Quark Pharmaceuticals (USA)
  11.2.1 Quark Pharmaceuticals (USA) Company Information
  11.2.2 Quark Pharmaceuticals (USA) RNA Based Therapeutics Product Offered
  11.2.3 Quark Pharmaceuticals (USA) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Quark Pharmaceuticals (USA) Main Business Overview
  11.2.5 Quark Pharmaceuticals (USA) Latest Developments
11.3 Alnylam Pharmaceuticals (USA)
  11.3.1 Alnylam Pharmaceuticals (USA) Company Information
  11.3.2 Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Product Offered
  11.3.3 Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Alnylam Pharmaceuticals (USA) Main Business Overview
  11.3.5 Alnylam Pharmaceuticals (USA) Latest Developments
11.4 Dicerna Pharmaceuticals (USA)
  11.4.1 Dicerna Pharmaceuticals (USA) Company Information
  11.4.2 Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Product Offered
  11.4.3 Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Dicerna Pharmaceuticals (USA) Main Business Overview
  11.4.5 Dicerna Pharmaceuticals (USA) Latest Developments
11.5 Tekmira Pharmaceuticals Corp. (Canada)
  11.5.1 Tekmira Pharmaceuticals Corp. (Canada) Company Information
  11.5.2 Tekmira Pharmaceuticals Corp. (Canada) RNA Based Therapeutics Product Offered
  11.5.3 Tekmira Pharmaceuticals Corp. (Canada) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Tekmira Pharmaceuticals Corp. (Canada) Main Business Overview
  11.5.5 Tekmira Pharmaceuticals Corp. (Canada) Latest Developments
11.6 Benitec Biopharma Limited (Australia)
  11.6.1 Benitec Biopharma Limited (Australia) Company Information
  11.6.2 Benitec Biopharma Limited (Australia) RNA Based Therapeutics Product Offered
  11.6.3 Benitec Biopharma Limited (Australia) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Benitec Biopharma Limited (Australia) Main Business Overview
  11.6.5 Benitec Biopharma Limited (Australia) Latest Developments
11.7 Genzyme Corporation (USA)
  11.7.1 Genzyme Corporation (USA) Company Information
  11.7.2 Genzyme Corporation (USA) RNA Based Therapeutics Product Offered
  11.7.3 Genzyme Corporation (USA) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Genzyme Corporation (USA) Main Business Overview
  11.7.5 Genzyme Corporation (USA) Latest Developments
11.8 Silence Therapeutics PLC (UK)
  11.8.1 Silence Therapeutics PLC (UK) Company Information
  11.8.2 Silence Therapeutics PLC (UK) RNA Based Therapeutics Product Offered
  11.8.3 Silence Therapeutics PLC (UK) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Silence Therapeutics PLC (UK) Main Business Overview
  11.8.5 Silence Therapeutics PLC (UK) Latest Developments
11.9 Cenix BioScience GmbH (Germany)
  11.9.1 Cenix BioScience GmbH (Germany) Company Information
  11.9.2 Cenix BioScience GmbH (Germany) RNA Based Therapeutics Product Offered
  11.9.3 Cenix BioScience GmbH (Germany) RNA Based Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Cenix BioScience GmbH (Germany) Main Business Overview
  11.9.5 Cenix BioScience GmbH (Germany) Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. RNA Based Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. RNA Based Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of qRT-PCR
Table 4. Major Players of RNA Interference (RNAi) Technologies
Table 5. Major Players of RNA Antisense
Table 6. Major Players of Inhibition
Table 7. Major Players of Microarrays
Table 8. Major Players of Labeling
Table 9. Major Players of Purification
Table 10. RNA Based Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global RNA Based Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 12. Global RNA Based Therapeutics Market Size Market Share by Type (2020-2025)
Table 13. RNA Based Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 14. Global RNA Based Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 15. Global RNA Based Therapeutics Market Size Market Share by Application (2020-2025)
Table 16. Global RNA Based Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 17. Global RNA Based Therapeutics Revenue Market Share by Player (2020-2025)
Table 18. RNA Based Therapeutics Key Players Head office and Products Offered
Table 19. RNA Based Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global RNA Based Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 23. Global RNA Based Therapeutics Market Size Market Share by Region (2020-2025)
Table 24. Global RNA Based Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 25. Global RNA Based Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 26. Americas RNA Based Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 27. Americas RNA Based Therapeutics Market Size Market Share by Country (2020-2025)
Table 28. Americas RNA Based Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 29. Americas RNA Based Therapeutics Market Size Market Share by Type (2020-2025)
Table 30. Americas RNA Based Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Americas RNA Based Therapeutics Market Size Market Share by Application (2020-2025)
Table 32. APAC RNA Based Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 33. APAC RNA Based Therapeutics Market Size Market Share by Region (2020-2025)
Table 34. APAC RNA Based Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. APAC RNA Based Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Europe RNA Based Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 37. Europe RNA Based Therapeutics Market Size Market Share by Country (2020-2025)
Table 38. Europe RNA Based Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 39. Europe RNA Based Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 40. Middle East & Africa RNA Based Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 41. Middle East & Africa RNA Based Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 42. Middle East & Africa RNA Based Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 43. Key Market Drivers & Growth Opportunities of RNA Based Therapeutics
Table 44. Key Market Challenges & Risks of RNA Based Therapeutics
Table 45. Key Industry Trends of RNA Based Therapeutics
Table 46. Global RNA Based Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 47. Global RNA Based Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 48. Global RNA Based Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 49. Global RNA Based Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 50. ISIS pharmaceuticals (USA) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 51. ISIS pharmaceuticals (USA) RNA Based Therapeutics Product Offered
Table 52. ISIS pharmaceuticals (USA) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. ISIS pharmaceuticals (USA) Main Business
Table 54. ISIS pharmaceuticals (USA) Latest Developments
Table 55. Quark Pharmaceuticals (USA) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 56. Quark Pharmaceuticals (USA) RNA Based Therapeutics Product Offered
Table 57. Quark Pharmaceuticals (USA) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Quark Pharmaceuticals (USA) Main Business
Table 59. Quark Pharmaceuticals (USA) Latest Developments
Table 60. Alnylam Pharmaceuticals (USA) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 61. Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Product Offered
Table 62. Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Alnylam Pharmaceuticals (USA) Main Business
Table 64. Alnylam Pharmaceuticals (USA) Latest Developments
Table 65. Dicerna Pharmaceuticals (USA) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 66. Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Product Offered
Table 67. Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Dicerna Pharmaceuticals (USA) Main Business
Table 69. Dicerna Pharmaceuticals (USA) Latest Developments
Table 70. Tekmira Pharmaceuticals Corp. (Canada) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 71. Tekmira Pharmaceuticals Corp. (Canada) RNA Based Therapeutics Product Offered
Table 72. Tekmira Pharmaceuticals Corp. (Canada) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Tekmira Pharmaceuticals Corp. (Canada) Main Business
Table 74. Tekmira Pharmaceuticals Corp. (Canada) Latest Developments
Table 75. Benitec Biopharma Limited (Australia) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 76. Benitec Biopharma Limited (Australia) RNA Based Therapeutics Product Offered
Table 77. Benitec Biopharma Limited (Australia) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Benitec Biopharma Limited (Australia) Main Business
Table 79. Benitec Biopharma Limited (Australia) Latest Developments
Table 80. Genzyme Corporation (USA) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 81. Genzyme Corporation (USA) RNA Based Therapeutics Product Offered
Table 82. Genzyme Corporation (USA) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Genzyme Corporation (USA) Main Business
Table 84. Genzyme Corporation (USA) Latest Developments
Table 85. Silence Therapeutics PLC (UK) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 86. Silence Therapeutics PLC (UK) RNA Based Therapeutics Product Offered
Table 87. Silence Therapeutics PLC (UK) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Silence Therapeutics PLC (UK) Main Business
Table 89. Silence Therapeutics PLC (UK) Latest Developments
Table 90. Cenix BioScience GmbH (Germany) Details, Company Type, RNA Based Therapeutics Area Served and Its Competitors
Table 91. Cenix BioScience GmbH (Germany) RNA Based Therapeutics Product Offered
Table 92. Cenix BioScience GmbH (Germany) RNA Based Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Cenix BioScience GmbH (Germany) Main Business
Table 94. Cenix BioScience GmbH (Germany) Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. RNA Based Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNA Based Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. RNA Based Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. RNA Based Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. RNA Based Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global RNA Based Therapeutics Market Size Market Share by Type in 2024
Figure 10. RNA Based Therapeutics in Cardiovascular
Figure 11. Global RNA Based Therapeutics Market: Cardiovascular (2020-2025) & ($ millions)
Figure 12. RNA Based Therapeutics in Kidney Diseases
Figure 13. Global RNA Based Therapeutics Market: Kidney Diseases (2020-2025) & ($ millions)
Figure 14. RNA Based Therapeutics in Oncology
Figure 15. Global RNA Based Therapeutics Market: Oncology (2020-2025) & ($ millions)
Figure 16. RNA Based Therapeutics in Infectious Diseases
Figure 17. Global RNA Based Therapeutics Market: Infectious Diseases (2020-2025) & ($ millions)
Figure 18. RNA Based Therapeutics in Metabolic Disorders
Figure 19. Global RNA Based Therapeutics Market: Metabolic Disorders (2020-2025) & ($ millions)
Figure 20. Global RNA Based Therapeutics Market Size Market Share by Application in 2024
Figure 21. Global RNA Based Therapeutics Revenue Market Share by Player in 2024
Figure 22. Global RNA Based Therapeutics Market Size Market Share by Region (2020-2025)
Figure 23. Americas RNA Based Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. APAC RNA Based Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Europe RNA Based Therapeutics Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa RNA Based Therapeutics Market Size 2020-2025 ($ millions)
Figure 27. Americas RNA Based Therapeutics Value Market Share by Country in 2024
Figure 28. United States RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC RNA Based Therapeutics Market Size Market Share by Region in 2024
Figure 33. APAC RNA Based Therapeutics Market Size Market Share by Type (2020-2025)
Figure 34. APAC RNA Based Therapeutics Market Size Market Share by Application (2020-2025)
Figure 35. China RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. India RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe RNA Based Therapeutics Market Size Market Share by Country in 2024
Figure 42. Europe RNA Based Therapeutics Market Size Market Share by Type (2020-2025)
Figure 43. Europe RNA Based Therapeutics Market Size Market Share by Application (2020-2025)
Figure 44. Germany RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. France RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. UK RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa RNA Based Therapeutics Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa RNA Based Therapeutics Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa RNA Based Therapeutics Market Size Market Share by Application (2020-2025)
Figure 52. Egypt RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries RNA Based Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. APAC RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Europe RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. United States RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Canada RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Mexico RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Brazil RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. China RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Japan RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Korea RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. India RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Australia RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Germany RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. France RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. UK RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Italy RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Russia RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Egypt RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. South Africa RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Israel RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 79. Turkey RNA Based Therapeutics Market Size 2026-2031 ($ millions)
Figure 80. Global RNA Based Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global RNA Based Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries RNA Based Therapeutics Market Size 2026-2031 ($ millions)